These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27897323)

  • 1. Prognostic durability of liver fibrosis tests and improvement in predictive performance for mortality by combining tests.
    Bertrais S; Boursier J; Ducancelle A; Oberti F; Fouchard-Hubert I; Moal V; Calès P
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1240-1249. PubMed ID: 27897323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.
    Boursier J; Vergniol J; Guillet A; Hiriart JB; Lannes A; Le Bail B; Michalak S; Chermak F; Bertrais S; Foucher J; Oberti F; Charbonnier M; Fouchard-Hubert I; Rousselet MC; Calès P; de Lédinghen V
    J Hepatol; 2016 Sep; 65(3):570-8. PubMed ID: 27151181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C.
    Vergniol J; Boursier J; Coutzac C; Bertrais S; Foucher J; Angel C; Chermak F; Hubert IF; Merrouche W; Oberti F; de Lédinghen V; Calès P
    Hepatology; 2014 Jul; 60(1):65-76. PubMed ID: 24519328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Single Test Combining Blood Markers and Elastography is More Accurate Than Other Fibrosis Tests in the Main Causes of Chronic Liver Diseases.
    Ducancelle A; Leroy V; Vergniol J; Sturm N; Le Bail B; Zarski JP; Nguyen Khac E; Salmon D; de Ledinghen V; Calès P
    J Clin Gastroenterol; 2017 Aug; 51(7):639-649. PubMed ID: 28692443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
    Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
    Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.
    Vergniol J; Foucher J; Terrebonne E; Bernard PH; le Bail B; Merrouche W; Couzigou P; de Ledinghen V
    Gastroenterology; 2011 Jun; 140(7):1970-9, 1979.e1-3. PubMed ID: 21376047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease.
    Staufer K; Halilbasic E; Spindelboeck W; Eilenberg M; Prager G; Stadlbauer V; Posch A; Munda P; Marculescu R; Obermayer-Pietsch B; Stift J; Lackner C; Trauner M; Stauber RE
    United European Gastroenterol J; 2019 Oct; 7(8):1113-1123. PubMed ID: 31662868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia.
    Vinikoor MJ; Sinkala E; Mweemba A; Zanolini A; Mulenga L; Sikazwe I; Fried MW; Eron JJ; Wandeler G; Chi BH
    Liver Int; 2015 Jul; 35(7):1886-92. PubMed ID: 25581487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel scores combining AFP with non-invasive markers for prediction of liver fibrosis in chronic hepatitis C patients.
    Gamil M; Alboraie M; El-Sayed M; Elsharkawy A; Asem N; Elbaz T; Mohey M; Abbas B; Mehrez M; Esmat G
    J Med Virol; 2018 Jun; 90(6):1080-1086. PubMed ID: 29315641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.
    Başar O; Yimaz B; Ekiz F; Giniş Z; Altinbaş A; Aktaş B; Tuna Y; Çoban S; Delibaş N; Yüksel O
    Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):152-8. PubMed ID: 23391746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified follow-up of patients with mild chronic hepatitis C in areas with limited access to antiviral therapy.
    Lens S; Torres F; Bonacci M; Bartres C; Pocurull A; Mariño Z; Londoño MC; Rodríguez-Tajes S; Forns X
    Dig Liver Dis; 2019 Jun; 51(6):875-881. PubMed ID: 30558865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of aspartate aminotransferase to platelet ratio for diagnosis of liver fibrosis and prediction of postoperative prognosis in infants with biliary atresia.
    Yang LY; Fu J; Peng XF; Pang SY; Gao KK; Chen ZR; He LJ; Wen Z; Wang H; Li L; Wang FH; Yu JK; Xu Y; Gong ST; Xia HM; Liu HY
    World J Gastroenterol; 2015 May; 21(19):5893-900. PubMed ID: 26019453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease.
    Petta S; Vanni E; Bugianesi E; Di Marco V; Cammà C; Cabibi D; Mezzabotta L; Craxì A
    Liver Int; 2015 May; 35(5):1566-73. PubMed ID: 24798049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV.
    Peters MG; Bacchetti P; Boylan R; French AL; Tien PC; Plankey MW; Glesby MJ; Augenbraun M; Golub ET; Karim R; Parkes J; Rosenberg W
    AIDS; 2016 Mar; 30(5):723-9. PubMed ID: 26595542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C.
    Boursier J; de Ledinghen V; Zarski JP; Rousselet MC; Sturm N; Foucher J; Leroy V; Fouchard-Hubert I; Bertrais S; Gallois Y; Oberti F; Dib N; Calès P
    Am J Gastroenterol; 2011 Jul; 106(7):1255-63. PubMed ID: 21468012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
    Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
    HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver-prognosis in chronic hepatitis C.
    Boursier J; Brochard C; Bertrais S; Michalak S; Gallois Y; Fouchard-Hubert I; Oberti F; Rousselet MC; Calès P
    Aliment Pharmacol Ther; 2014 Jul; 40(2):178-88. PubMed ID: 24889599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease.
    Siddiqui MS; Patidar KR; Boyett S; Luketic VA; Puri P; Sanyal AJ
    Liver Int; 2016 Apr; 36(4):572-9. PubMed ID: 26713759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
    Ucar F; Sezer S; Ginis Z; Ozturk G; Albayrak A; Basar O; Ekiz F; Coban S; Yuksel O; Armutcu F; Akbal E
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.